Neil Drake - Net Worth and Insider Trading

Neil Drake Net Worth

The estimated net worth of Neil Drake is at least $2,730 dollars as of 2024-11-13. Neil Drake is the VP Research and Development of Obalon Therapeutics Inc and owns about 895 shares of Obalon Therapeutics Inc (OBLN) stock worth over $2,730. Details can be seen in Neil Drake's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil Drake has not made any transactions after 2018-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Neil Drake

To

Neil Drake Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Neil Drake owns 2 companies in total, including Obalon Therapeutics Inc (OBLN) , and Reshape Lifesciences Inc (RSLS) .

Click here to see the complete history of Neil Drake’s form 4 insider trades.

Insider Ownership Summary of Neil Drake

Ticker Comapny Transaction Date Type of Owner
OBLN Obalon Therapeutics Inc 2019-01-02 VP Research and Development
RSLS Reshape Lifesciences Inc 2017-02-01 VP of Research and Development

Neil Drake Latest Holdings Summary

Neil Drake currently owns a total of 1 stock. Neil Drake owns 895 shares of Obalon Therapeutics Inc (OBLN) as of March 15, 2018, with a value of $2,730.

Latest Holdings of Neil Drake

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OBLN Obalon Therapeutics Inc 2018-03-15 895 3.05 2,730

Holding Weightings of Neil Drake


Neil Drake Form 4 Trading Tracker

According to the SEC Form 4 filings, Neil Drake has made a total of 0 transactions in Obalon Therapeutics Inc (OBLN) over the past 5 years. The most-recent trade in Obalon Therapeutics Inc is the acquisition of 167 shares on March 15, 2018, which cost Neil Drake around $19,800.

Insider Trading History of Neil Drake

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Neil Drake Trading Performance

GuruFocus tracks the stock performance after each of Neil Drake's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neil Drake is -38.65%. GuruFocus also compares Neil Drake's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neil Drake within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Neil Drake's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Neil Drake

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -11.15 LIMIT LIMIT LIMIT LIMIT LIMIT

Neil Drake Ownership Network

Ownership Network List of Neil Drake

No Data

Ownership Network Relation of Neil Drake

Insider Network Chart

Neil Drake Owned Company Details

What does Obalon Therapeutics Inc do?

Who are the key executives at Obalon Therapeutics Inc?

Neil Drake is the VP Research and Development of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .

Obalon Therapeutics Inc (OBLN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Obalon Therapeutics Inc Insider Transactions

No Available Data

Neil Drake Mailing Address

Above is the net worth, insider trading, and ownership report for Neil Drake. You might contact Neil Drake via mailing address: 12020 Least Tern Court, San Diego Ca 92129.